Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.
Biomed Pharmacother
; 149: 112925, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35477218
Key words
2-AG; AM630 (PubChem CID: 4302963); Amygdala; CB2R; Fear extinction; JWH133 (PubChem CID: 6918505); JZL184 (PubChem CID: 25021165); Microglia; O7460 (PubChem CID: 132285144); Orexin; Orexin-A (PubChem CID: 92131430); PLX5622 (PubChem CID: 52936034); Rimonabant (PubChem CID: 104849); URB597 (PubChem CID: 1383884)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cannabinoids
/
Fear
Limits:
Animals
Language:
En
Journal:
Biomed Pharmacother
Year:
2022
Document type:
Article
Affiliation country:
Spain
Country of publication:
France